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Antimicrobial-drug resistance in hospitals is driven by failures of hospital hygiene, selective pressures
created by overuse of antibiotics, and mobile genetic elements that can encode bacterial resistance
mechanisms. Attention to hand hygiene is constrained by the time it takes to wash hands and by the adverse
effects of repeated handwashing on the skin. Alcohol-based hand rubs can overcome the time problem and
actually improve skin condition. Universal glove use could close gaps left by incomplete adherence to hand
hygiene. Various interventions have been described to improve antibiotic use. The most effective have been
programs restricting use of antibiotics and computer-based order forms for health providers.
The forces that drive antimicrobial-drug resistance
(failures of hospital hygiene, selective pressures created by
overuse of antibiotics, and mobile genetic elements that can
encode bacterial resistance mechanisms) have been discussed
at length (1-4). Despite this extensive knowledge base,
exhortations about resistance, and formal control guidelines
(5), drug resistance has continued to emerge, especially in
intensive care units (ICUs) (Figure 1).
In a survey in four U.S. medical centers (a public hospital,
a community hospital, a long-term care facility, and a
university hospital), 85% of 424 physicians noted that
antimicrobial-drug resistance was a major national problem;
55% thought that resistance was an issue for their patients
(6). At the root of the resistance problem are health-care
workers, who, although generally willing to do the right thing
to control antimicrobial-drug resistance, undervalue the
problem, do not know what the “right thing” is, or need an
easier way to do it. This review summarizes a “facilitated right
thing” approach to the problems of failed hygiene and antibiotic
pressures.
Hand Hygiene
In a recent survey of physicians (6), 45% considered poor
handwashing practices an important cause of antimicrobial-
drug resistance in hospitals, perhaps a reflection of health-
care workers’ markedly inflated view of their attention to
hand hygiene (Table 1) (7). In fact, in most surveys of
handwashing adherence, in various patient-care settings,
personnel have practiced appropriate hand hygiene in only
25% to 50% of opportunities. As we pass the sesquicentennial
of Semmelweis’ seminal observations on the importance of
hand hygiene in reducing the incidence of nosocomial
childbed fever, why does handwashing remain the most
breached infection control measure in hospitals? Two
frequently cited reasons are the large time commitment (up to
Figure 1. Rates of resistance in nosocomial infections reported in ICU
patients, National Nosocomial Infections Surveillance System, CDC.
Comparison of data from January-December 1999 with historical data.
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1 = Vancomycin/enterocci
2 = Methicillin/S. aureus
3 = Methicillin/CNS
4 = 3rd Ceph/E. coli**
5 = 3rd Ceph/K. pneumoniae**
6 = Imipenem/P. aeruginosa
7 = Quinolone/P. aeruginosa
8 = 3rd Ceph/P. aeruginosa
9 = 3rd Ceph/Enterobacter spp.
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Note: S. aureus = Staphylococcus aureus; CNS =
coagulase-negative staphylococci; 3rd Ceph =
reistance to third-generation cephalosporins (ceftri-
axone, cefotaxime, or ceftazidime); P. aeruginosa =
Pseudomonas aeruginosa; Quinolone = resistant to
either ciprofloxacin or ofloxacin.
*Percentage (%) increase in resistance rate of
current period (January-December 1999) compared
to mean rate of resistance over previous 5 years
(1994 through 1998): [(1999 rate - previous 5-year
mean rate)/previous 5-year mean rate] X 100.
**Resistance for Escherichia coli or  Klebsiella
pneumonia is the rate of nonsusceptibility of these
organisms to either 3rd Ceph group or aztreonam.
Table 1. Hospital personnel self-reported and observed handwashing
ratesa
Handwashing after
   patient contact
             N (%)
Self-reported rate (n=123) 104 (85)
Estimate of co-workers’   63 (51)
  rate (n=123)
Observed rate (n=173)   48 (28)
aFrom Chicago Antimicrobial Resistance Project and from data
adapted from Vernon et al. (7).189 Vol. 7, No. 2, March–April 2001 Emerging Infectious Diseases
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90 minutes per work shift if performed as recommended by
the Centers for Disease Control and Prevention [CDC]) and
the adverse effects of repeated handwashing on the skin (8).
Alcohol-Based Hand Rubs
If given a choice of changing human behavior (e.g.,
improving attention to hygiene and asepsis) or designing a
technologically foolproof device to control infections, go for the
device. For hand hygiene, we have the opportunity to fulfill
the infection control “prime directive”: use technologic
advances to improve behavior. How? Alcohol-based sinkless
hand rubs (Table 2) can overcome the time problems of
handwashing (9) and actually improve skin condition (10).
Handwashing requires approximately 45 to 90 seconds to
access and use a sink with running water, soap, and hand-
drying facilities; an alcohol-based hand rub can degerm hands
in less than 30 seconds and enhance killing of transient hand
flora.
Although use of alcohol for handwashing or scrubbing is
perceived as leading to dry skin, use of alcohol hand rubs,
without rinsing, is beneficial to skin, presumably because the
protective fats and oils remain on the hands as the alcohol
dries and because alcohol rubs contain emollients. In a study
comparing an alcohol gel hand rub to soap and water
handwashing, Boyce et al. reported that health-care workers
found that alcohol hand rub causes less skin dryness, is
accessible and convenient to use, and has a pleasant odor.
After the study, 92% of test participants agreed to use the
hand rub routinely (11).
Colonization Pressure and Universal Glove use
While alcohol-based hand rubs appear promising,
maintaining adherence may require ongoing educational
reenforcement, compliance monitoring, and feedback to
personnel. With such aggressive campaigns, hand hygiene
rates of 60% to 80% can be achieved. But is this enough? For
uncommon pathogens that may colonize or infect only a small
proportion of patients, indirect patient-to-patient cross-
transmission by the hands of health-care workers may be
interrupted readily by such adherence rates. However, when
“colonization pressure” is greater because of a large number of
colonized patients, such rates may not be sufficient. For
example, when 30% to 50% of patients are colonized with
vancomycin-resistant enterococci (VRE), even occasional
lapses in hand hygiene may be enough to sustain cross-
transmission (Figure 2) (12,13).
A “belt and suspenders” approach to the colonization
pressure dilemma has been to encourage use of disposable
examination gloves during contacts with patients and their
environment (2,14,15). In one study, the rate of nosocomial
Clostridium difficile-associated diarrhea was threefold lower
on “universal glove use” wards than on control wards (16). In
a study of VRE, 39% of personnel had contamination of
examination gloves by VRE after even brief contact with
infected or colonized patients; personnel hand contamination
was reduced 71% by use of gloves (17). Because even intact
upper body skin may be colonized by resistant bacteria such
as VRE (18) and environmental contamination by VRE is
common (19), we recommend that disposable examination
gloves be worn for all contact, even with intact skin or the
environment of at-risk patients. Gloves must be changed and
hands disinfected by an alcohol hand rub between patients,
because gloves are not a total barrier (17,20). In one
observational study of universal glove use, 96% of gloved
personnel removed gloves after leaving the patient’s room
(21). In that study, personnel cited a marked preference for
universal glove use over traditional contact precautions.
Because of the huge resistance iceberg (Figure 3), with as
many as 5 to 10 patients colonized with resistant bacteria for
every patient known to be infected, universal glove use may be
a more preferable infection control strategy than contact
precautions, which are applied only to the tip of the iceberg.
With universal glove use, gowning of personnel is
recommended only for self-protection, e.g., from blood and
body fluid exposures. In a study of the epidemiology and
control of VRE in a medical ICU and in a study of control of
VRE, methicillin-resistant Staphylococcus aureus, and
ceftazidime-resistant  Escherichia coli and Klebsiella
pneumoniae, gowns did not add value to universal glove use
(21,22). However, gowns may be of value for motivation (they
have increased compliance in some studies) (22), in outbreak
control (23), or in some heavily contaminated environments
such as burn units.
Prescription of Antibiotics
Antibiotic pressures may be more amenable to
intervention than hygiene practices. Prescribers want to do
Table 2. Potential benefits of alcohol-based sinkless hand degerming
agents
Soap and water
 handwashing Alcohol hand rub
Time required 30-120 seconds    10-30 seconds
Efficacy in       Good to        Excellent
  degerming      very good
Acceptance by Historically poor  Good to excellent
  personnel
Figure 2. Median number of days until acquisition of VRE in a
medical ICU; prevalence of VRE (“colonization pressure”) exerted a
greater effect on acquisition than did antibiotic use, i.e., time to
acquisition of VRE was shorter with high colonization pressure and
low antibiotic use than with the converse conditions (13).190 Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
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Figure 3. The dynamics of nosocomial resistance. Resistance iceberg
floating in an epicenter (2).
the right thing but may not always remember recommenda-
tions. Even though most health-care workers see inappropri-
ate use of antibiotics as an important cause of drug resistance,
many consider use of broader-spectrum antibiotics for longer
periods the way to stamp out resistant bacteria (6).
To simplify prescription of antibiotics, most hospitals use
“closed” formularies that limit prescribing options, often
based on competitive bidding, to one or two drugs per
antibiotic class. Clinical guidelines have become popular,
especially for common infections, such as community-
acquired pneumonia. Such guidelines may improve antibiotic
use, especially if results are audited, and feedback is provided
to prescribers. Use of order forms (24) and concurrent
feedback to prescribers or next-day review of antibiotic
appropriateness (25) also can improve prescriptions. The
most effective antibiotic interventions have been restriction
programs and computer-based order forms (so-called
provider-order entries).
Restrictions to Use of Antibiotics
Restricting use of antibiotics has been especially effective
in reducing cost and excess empiric use of broad-spectrum
drugs (26). In one large study of the effect of prior
authorization for selected drugs, a 32% decrease in
expenditure for parenteral antibiotics was accompanied by
increased susceptibility of bacterial isolates to beta-lactam
and quinolone antibiotics. There were no adverse effects on
clinical outcomes as measured by time to receipt of appropriate
antibiotics, survival, and discharge from hospital for patients
with bacteremia caused by gram-negative bacilli (27).
Computer Order Entry
Computer-based order entry for medical providers uses
technology to direct and improve prescription behavior and
thus fulfills the infection control prime directive (28). Order
entry systems for antibiotics (and other drugs) provide simple
messages to prescribers, such as the hospital’s suggested
indications for, or the local resistance patterns of, a selected
antibiotic. More sophisticated systems integrate results of
microbiology and other laboratory tests into decision-support
algorithms (29). Because they provide prescribing informa-
tion when it is needed, in a neutral, nonjudgmental, fact-
based format, computer order forms are efficient and well
accepted and can change prescribing behavior dramatically,
almost overnight.
Rotating Use of Antibiotics
The most recent intervention in antibiotic prescribing
has been renewed interest in rotating use, or cycling, of
antibiotics (30). Over 20 years ago, in a series of studies at the
Minneapolis Veterans’ Administration Hospital, the substi-
tution of amikacin for gentamicin and tobramycin as the
aminoglycoside of choice produced sustained decreases in the
prevalence of aminoglycoside-resistant gram-negative bacilli
(31). The higher serum levels of amikacin, and the infrequent
appearance in U.S. hospitals of amikacin-modifying enzymes
that could confer amikacin resistance in gram-negative bacilli,
were the underpinnings of the success of this strategy.
The more recent reports on cycling describe replacement
(or switch) therapy for empiric antibiotic choices (30,32-34).
Replacing ceftazidime with ciprofloxacin for empiric
treatment of suspected gram-negative bacterial infections in
a cardiac surgery ICU was associated with decreased
incidence of ventilator-associated pneumonia and bacteremia
caused by antibiotic-resistant gram-negative bacilli (33). In
another hospital, use of beta-lactam/beta-lactamase inhibitor
combinations to replace use of third-generation cephalospor-
ins and clindamycin was associated with decreased rates of
colonization by VRE (34); a follow-up study reported that
these formulary manipulations were associated with decreasing
numbers of patients from whom methicillin-resistant S. aureus
and ceftazidime-resistant K. pneumoniae were cultured but
increased rates of resistant Acinetobacter (35). Rotating use of
fourth-generation cephalosporins, quinolones, carbapenems,
and beta-lactam/beta-lactamase inhibitor combinations is
being studied in several hospital ICUs.
Cycling of antibiotics is most likely to be effective for
limited periods in closed environments, such as ICUs, but this
approach requires careful microbiologic monitoring because
of the monotonic selective pressure of a single agent and the
possible emergence of resistance to unrelated classes of drugs
caused by genetic linkage of resistance mechanisms (30,36).
As the size of the patient population under study increases,
availability of various classes of drugs may be more effective at
reducing the risk of emergence of resistance and may be a better
strategy than cycling (37).
Conclusions
Control of antibiotic resistance requires aggressive
implementation of several strategies (2): ongoing surveillance
of resistance; molecular typing of isolates, usually using
pulsed-field gel electrophoresis (38,39) when rates of
resistance increase; using hygiene controls to limit spread of
single (clonal) strains and antibiotic controls to limit spread of
multiple (polyclonal) strains of resistant bacteria; and
enlisting administrative support. Monitoring adherence of
health-care workers to control measures and feedback of
individual and ward rates of hygiene adherence and antibiotic
resistance are central components of health-care worker
education and motivation. Mathematical modeling has been
used to judge the value of infection control activities. In these
calculations, screening and cohorting of infected and
colonized patients are the most effective control measures
(11), although creating and maintaining cohorts are often
logistically and technically difficult.
Current infection control strategies are aimed at the
hygiene and antimicrobial engines that drive resistance. To
ulfill the infection control prime directive, we must harness
technology to improve and direct adherence to these191 Vol. 7, No. 2, March–April 2001 Emerging Infectious Diseases
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strategies. Future approaches may control or eliminate the
bacterial events that underlie evolution of resistance.
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